Masimo Corporation (MASI)
NASDAQ: MASI · IEX Real-Time Price · USD
106.76
-0.65 (-0.61%)
At close: Jul 19, 2024, 4:00 PM
106.77
+0.01 (0.01%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
Masimo Revenue
Masimo had revenue of $1.98B in the twelve months ending March 30, 2024. Revenue in the quarter ending March 30, 2024 was $492.80M. In the year 2023, Masimo had annual revenue of $2.05B with 0.60% growth.
Revenue (ttm)
$1.98B
Revenue Growth
-13.96%
P/S Ratio
2.87
Revenue / Employee
$519,974
Employees
3,800
Market Cap
5.68B USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 30, 2023 | 2.05B | 12.30M | 0.60% |
Dec 31, 2022 | 2.04B | 892.10M | 78.00% |
Jan 1, 2022 | 1.14B | -44.00K | -0.00% |
Jan 2, 2021 | 1.14B | 205.91M | 21.96% |
Dec 28, 2019 | 937.84M | - | - |
Dec 29, 2018 | 937.84M | 79.55M | 9.27% |
Dec 30, 2017 | 858.29M | 145.39M | 20.39% |
Dec 31, 2016 | 712.90M | 82.79M | 13.14% |
Jan 2, 2016 | 630.11M | 43.47M | 7.41% |
Jan 3, 2015 | 586.64M | 39.40M | 7.20% |
Dec 28, 2013 | 547.25M | 54.01M | 10.95% |
Dec 29, 2012 | 493.23M | 54.25M | 12.36% |
Dec 31, 2011 | 438.99M | 33.58M | 8.28% |
Jan 1, 2011 | 405.41M | 56.29M | 16.12% |
Jan 2, 2010 | 349.12M | 42.04M | 13.69% |
Jan 3, 2009 | 307.07M | 50.79M | 19.82% |
Dec 29, 2007 | 256.29M | 31.95M | 14.24% |
Dec 31, 2006 | 224.34M | 116.45M | 107.93% |
Dec 31, 2005 | 107.89M | 38.53M | 55.56% |
Dec 31, 2004 | 69.36M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Organon & Co. | 6.35B |
Option Care Health | 4.43B |
Bausch + Lomb | 4.31B |
DENTSPLY SIRONA | 3.94B |
Acadia Healthcare Company | 2.99B |
R1 RCM | 2.31B |
Stevanato Group | 1.18B |
Glaukos | 326.43M |
MASI News
- 4 days ago - MASI ANNOUNCEMENT: If You Have Suffered Losses in Masimo (NASDAQ: MASI), You Are Encouraged to Contact The Rosen Law Firm About Your Rights - GlobeNewsWire
- 5 days ago - Politan Comments on Masimo's Latest Entrenchment Maneuvers - Business Wire
- 6 days ago - Masimo initiates legal action against activist investor Politan - Reuters
- 6 days ago - Masimo Files Complaint Seeking Injunction Requiring Politan to Correct Material Misstatements - Business Wire
- 6 days ago - Rosen Law Firm Encourages Masimo Corporation Investors to Inquire About Securities Class Action Investigation - MASI - PRNewsWire
- 6 days ago - Leading Proxy Advisory Firm ISS Recommends Masimo Shareholders Vote FOR Both of Politan's Director Nominees - Business Wire
- 6 days ago - Proxy advisor ISS says Masimo change is 'absolutely necessary' in brutal report - CNBC
- 6 days ago - Masimo Responds to Politan's Continuing Misrepresentations - Business Wire